Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bolarin JA et al (2020) Therapeutic drugs for SARS-CoV-2 treatment: current state and perspective. Int Immunopharmacol 90:107228. https://doi.org/10.1016/j.intimp.2020.107228
Bora KS, Sharma A (2010) Neuroprotective effect of Artemisia absinthium L. on focal ischemia and reperfusion-induced cerebral injury. J Ethnopharmacol 129:403–409
Boukhatem MN, Setzer WN (2020) Aromatic herbs, medicinal plant-derived essential oils, and phytochemical extracts as potential therapies for coronaviruses: future perspectives. Plants 9:800. https://doi.org/10.3390/plants9060800
Brisibe EA et al (2009) Nutritional characterisation and antioxidant capacity of different tissues of Artemisia annua L. Food Chem 115:1240–1246
Cheong DH, Tan WD, Wong WF, Tran T (2020) Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases. Pharmacol Res. https://doi.org/10.1016/j.phrs.2020.104901
Chinese Clinical Trials Registry (2020) http://www.chictr.org.cn/searchprojen.aspx?title=&officialname=&subjectid=&secondaryid=&applier=&studyleader=ðicalcommitteesanction=&sponsor=&studyailment=COVID-19&studyailmentcode=&studytype=0&studystage=0&studydesign=0&minstudyexecutetime=&maxstudyexecutetime=&recruitmentstatus=0&gender=0&agreetosign=&secsponsor=®no=®status=0&country=&province=&city=&institution=&institutionlevel=&measure=arte&intercode=&sourceofspends=&createyear=0&isuploadrf=&whetherpublic=&btngo=btn&verifycode=&page=1. Accessed 20/10/2020
COVID19 Clinical Trials (2020) https://clinicaltrials.gov/. Accessed 15 August 2020
Dai R, Xiao X, Peng F, Li M, Gong G (2016) Artesunate, an anti-malarial drug, has a potential to inhibit HCV replication. Virus Genes 52:22–28
De Biasi S et al (2020) Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun 11:1–17
Dhifi W, Bellili S, Jazi S, Bahloul N, Mnif W (2016) Essential oils’ chemical characterization and investigation of some biological activities: a critical review. Medicines 3:25
Duke JA (1992) Database of phytochemical constituents of GRAS herbs and other economic plants. CRC Press, Boca Raton
Efferth T (2018) Beyond malaria: the inhibition of viruses by artemisinin-type compounds. Biotechnol Adv 36:1730–1737. https://doi.org/10.1016/j.biotechadv.2018.01.001
Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJ, Marschall M (2008) The antiviral activities of artemisinin and artesunate. Clin Infect Dis 47:804–811
Ferreira JF (2007) Nutrient deficiency in the production of artemisinin, dihydroartemisinic acid, and artemisinic acid in Artemisia annua L. J Agric Food Chem 55:1686–1694
Funk VA et al (2005) Everywhere but antarctica: using a supertree to understand the diversity and distribution of the compositae. Biol Skr 55:343–374
Ghafoor A (2002) Flora of Pakistan. asteraceae (1) Anthemideae vol 207. Missouri Botanical Garden, USA, Department of Botany, University of Karachi, Karachi-Pakistan
Haq FU et al. (2020) Artemisia annua: trials are needed for COVID‐19. Phytother Res
Honscheid A, Rink L, Haase H (2009) T-lymphocytes: a target for stimulatory and inhibitory effects of zinc ions. Endocr Metab Immune Disorders Drug Targets (Formerly Current Drug Targets-Immune, Endocrine and Metabolic Disorders) 9:132–144
Hu S-y (1965) The compositae of China Taiwan Museum. Q J 18:1–136
Huang F et al. (2020) A review of therapeutic agents and Chinese herbal medicines against SARS-COV-2 (COVID-19). Pharmacol Res 104929
IqbalHussain FAK, Khattak MUR (2011) Evaluation of inorganic profile of selected medicinal plants of Khyber Pakhtunkhwa Pakistan. World Appl Sci J 12:1464–1468
Jana S, Iram S, Thomas J, Hayat MQ, Pannecouque C, Dehaen W (2017) Application of the triazolization reaction to afford dihydroartemisinin derivatives with anti-HIV activity. Molecules 22:303
Jassim SAA, Naji MA (2003) Novel antiviral agents: a medicinal plant perspective. J Appl Microbiol 95:412–427
Jiang S, Cui Q, Ni B, Chen Y, Tan Y, Chen W, Chen YZ (2020) Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19. Pharmacol Res 159:104989
Jin Y-H et al (2020) A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 7:4
Jo S, Kim H, Kim S, Shin DH, Kim MS (2019) Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors. Chem Biol Drug Design 94:2023–2030
Jo S, Kim S, Shin DH, Kim M-S (2020) Inhibition of SARS-CoV 3CL protease by flavonoids. J Enzyme Inhib Med Chem 35:145–151
Khlifi D, Sghaier RM, Amouri S, Laouini D, Hamdi M, Bouajila J (2013) Composition and anti-oxidant, anti-cancer and anti-inflammatory activities of Artemisia herba-alba, Ruta chalpensis L and Peganum harmala L. Food Chem Toxicol 55:202–208
Kim W-S et al (2015) Anti-inflammatory, antioxidant and antimicrobial effects of Artemisinin extracts from Artemisia annua L. Korean J Physiol Pharmacol 19:21
Kitamura S (1939) A classification of Artemisia. Acta Phytotax Geobot 8:62–66
Kitamura S (1940) Compositae Japonicae. Pars secunda Mem Coll Sci Kyoto Univ 15:258–446
Kumar S, Kumari R (2018) Artemisia: a medicinally Important Genus. J Complement Med Alt Healthcare 7:555723. https://doi.org/10.19080/JCMAH.2018.07.555723
Kurşat M, Cİvelek Ş, Türkoğlu İ, Tabur S, Gür N, (2015) A new species of subgenus Seriphidium of Artemisia L. (Asteraceae) from Turkey. Turk J Bot 39:88–95
Laila U et al (2019) Role of medicinal plants in HIV/AIDS therapy. Clin Exp Pharmacol Physiol 46:1063–1073. https://doi.org/10.1111/1440-1681.13151
Law S, Leung AW, Xu C (2020) Is the traditional Chinese herb “Artemisia annua” possible to fight against COVID-19? Integr Med Res 9
Li S-Y et al (2005) Identification of natural compounds with antiviral activities against SARS-associated coronavirus. Antivir Res 67:18–23
Lin L, Han Y, Yang Z (2003) Clinical observation on 103 patients of severe acute respiratory syndrome treated by integrative traditional Chinese and Western Medicine. Chin J Integr Trad Western Med 23:409–413
Ling Y (1982) On the system of the genus Artemisia L and the relationship with its allies. Bull Lab North East For Inst 2:1–60
Liu X, Cao J, Huang G, Zhao Q, Shen J (2019) Biological activities of artemisinin derivatives beyond malaria. Curr Top Med Chem 19:205–222. https://doi.org/10.2174/1568026619666190122144217
Lubbe A, Seibert I, Klimkait T, Van der Kooy F (2012) Ethnopharmacology in overdrive: the remarkable anti-HIV activity of Artemisia annua. J Ethnopharmacol 141:854–859
Lutgen P (2019) No toxicity detected for Artemisia annua or afra Review published online on August 5, 2019 on http://Malariaworld.org
Mannan A, Ahmed I, Arshad W, Asim MF, Qureshi RA, Hussain I, Mirza B (2010) Survey of artemisinin production by diverse Artemisia species in northern Pakistan. Malar J 9:310. https://doi.org/10.1186/1475-2875-9-310
Martín J, Torrell M, Korobkov AA, Vallès J (2003) Palynological features as a systematic marker in Artemisia L. and related genera (Asteraceae, Anthemideae)-II: implications for Subtribe Artemisiinae delimitation. Plant Biol 5:85–93. https://doi.org/10.1055/s-2003-37979
Martínez MJA, Del Olmo LMB, Ticona LA, Benito PB (2012) The Artemisia L. genus: a review of bioactive sesquiterpene lactones. Studies in natural products chemistry, vol 37. Elsevier, Amstredam, pp 43–65
Milbradt J, Auerochs S, Korn K, Marschall M (2009) Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate. J Clin Virol 46:24–28
Naesens L, Bonnafous P, Agut H, De Clercq E (2006) Antiviral activity of diverse classes of broad-acting agents and natural compounds in HHV-6-infected lymphoblasts. J Clin Virol 37:S69–S75
Nagamune K, Moreno SN, Sibley LD (2007) Artemisinin-resistant mutants of Toxoplasma gondii have altered calcium homeostasis. Antimicrob Agents Chemother 51:3816–3823
Naghavi MR, Alaeimoghadam F, Ghafoori H (2014) Artemisia species from iran as valuable resources for medicinal uses. World Acad Sci Eng Technol 11:1058–1064
Nigam M et al (2019) Bioactive compounds and health benefits of artemisia species. Nat Prod Commun 14:1–17. https://doi.org/10.1177/1934578X19850354
No toxicity detected for Artemisia annua or afra (2019) www.malariaworld.org.
Obeid S et al (2013) Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication. PLoS ONE 8:e81783
Paeshuyse J et al (2006) Hemin potentiates the anti-hepatitis C virus activity of the antimalarial drug artemisinin. Biochem Biophys Res Commun 348:139–144
Poisson-Benatouil C (2020) Action of Artemisia annua on adaptive immunity in COVID-19 infections. A concept note. pp 22. Available from: https://lavierebelle.org/action-del-artemisia-annua-sur-l?lang=en. Accessed 19 Sept 2020
Poljakov PP (1961) Systematic studies in the genus Artemisia L. Trudy Ins Bot Akad Nauk Kazakh SSR Alma Acta 11:134–177
Qi F et al (2013) Traditional Chinese medicine and related active compounds: a review of their role on hepatitis B virus infection. Drug Discov Ther 7:212–224
Qian RS, Li Z, Yu J, Ma DJ (1982) The immunologic and antiviral effect of qinghaosu. J Trad Chin Med 2:271–276
Romero MR, Efferth T, Serrano MA, Castaño B, Macias RI, Briz O, Marin JJ (2005) Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system. Antiv Res 68:75–83
Romero MR, Serrano MA, Vallejo M, Efferth T, Alvarez M, Marin JJ (2006) Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV). Planta Med 72:1169–1174
Sehailia M, Chemat S (2020) Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19. J Biomol Struct Dyn. https://doi.org/10.1080/07391102.2020.1796809
Tong Y, Deng Z (2020) An aurora of natural products-based drug discovery is coming. Synth Syst Biotechnol 5:92–96. https://doi.org/10.1016/j.synbio.2020.05.003
Wang W-M (2004) On the origin and development of Artemisia (Asteraceae) in the geological past. Bot J Linn Soc 145:331–336. https://doi.org/10.1111/j.1095-8339.2004.00287.x
Wang X et al (2020a) Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production. Antivir Res 179:104810
Wang Y, Zeng X, Zhao Y, Chen W, Chen YZ (2020b) The pros and cons of traditional Chinese medicines in the treatment of COVID-19. Pharmacol Res 157:104873. https://doi.org/10.1016/j.phrs.2020.104873
WHO (2015) Guidelines for the treatment of malaria, 3rd edn. World Health Organization, Geneva
WHO (2020a) Coronavirus disease 2019 (COVID-19): situation report, 72. In, 2020a. World Health Organization, Geneva
WHO (2020b) WHO Coronavirus Disease (COVID-19) Dashboard. World Health Organization. https://covid19.who.int/
WHO Director-General’s Remark at the media briefing on 2019 n-CoV on 11 February 2020 (2020c). https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020. Accessed 31 March 2021.
Woerdenbag HJ, Lugt CB, Pras N (1990) Artemisia annua L.: a source of novel antimalarial drugs. Pharm Weekbl 12:169–181
Wright CW (2001) Artemisia. Medicinal and Aromatic Plant—industrial profile. CRC Press, London
Yang B, Zhou S, Li C, Wang Y (2010) Toxicity and side effects of artemisiae annuae CQ-189. J Chin Mater Med 35:204–207
Yang R et al (2020) Chemical composition and pharmacological mechanism of Qingfei Paidu Decoction and Ma Xing Shi Gan Decoction against Coronavirus Disease 2019 (COVID-19): in silico and experimental study. Pharmacol Res 157:104820
Yu H, Zhong S (2001) Artemisia species in traditional Chinese medicine and the discovery of artemisinin. CRC Press, Boca Raton